檢索結果 - Argyro Repa
- Showing 1 - 8 results of 8
-
1
-
2
Patterns of comorbidities differentially affect long-term functional evolution and disease activity in patients with ‘difficult to treat’ rheumatoid arthritis 由 Antonios Bertsias, Irini Flouri, Argyro Repa, Nestor Avgoustidis, Eleni Kalogiannaki, Sofia Pitsigavdaki, George Βertsias, Prodromos Sidiropoulos
出版 2024Artigo -
3
Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis 由 Christianna Choulaki, Garyfallia Papadaki, Argyro Repa, Eleni Kampouraki, Konstantinos Kambas, Konstantinos Ritis, George Βertsias, Dimitrios T. Boumpas, Prodromos Sidiropoulos
出版 2015Artigo -
4
Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus 由 Christina Adamichou, Irini Genitsaridi, Dionysis Nikolopoulos, Myrto Nikoloudaki, Argyro Repa, Alessandra Bortoluzzi, Antonis Fanouriakis, Prodromos Sidiropoulos, Dimitrios T. Boumpas, George Βertsias
出版 2021Artigo -
5
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attain... 由 Sofia Pitsigavdaki, Myrto Nikoloudaki, Panagiotis Garantziotis, Ettore Silvagni, Argyro Repa, Antônio Carlos Marangoni, Irini Flouri, Nestor Avgoustidis, Konstantinos Parperis, Antonis Fanouriakis, Marcello Govoni, Prodromos Sidiropoulos, Dimitrios T. Boumpas, Alessandra Bortoluzzi, George Βertsias
出版 2024Artigo -
6
Combination of clinical factors predicts successful glucocorticoid withdrawal in systemic lupus erythematosus (SLE): results from a multicentre, retrospective cohort study 由 Spyridon Katechis, Sofia Pitsigavdaki, Myrto Nikoloudaki, Ettore Silvagni, Argyro Repa, Antônio Carlos Marangoni, Irini Flouri, Nestor Avgoustidis, Konstantinos Parperis, Marcello Govoni, Prodromos Sidiropoulos, Dimitrios T. Boumpas, Antonis Fanouriakis, George Βertsias, Alessandra Bortoluzzi
出版 2025Artigo -
7
Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study 由 Myrto Nikoloudaki, Dionysis Nikolopoulos, Sofia Koutsoviti, Irini Flouri, Noemin Kapsala, Argyro Repa, Pelagia Katsimbri, Evangelos Theotikos, Sofia Pitsigavdaki, K. Pateromichelaki, Antonios Bertsias, Antonia Elezoglou, Prodromos Sidiropoulos, Antonis Fanouriakis, Dimitrios T. Boumpas, George Βertsias
出版 2023Artigo -
8
Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity 由 Nikolaos Panousis, George Βertsias, Halit Ongen, Irini Gergianaki, Maria G. Tektonidou, Maria Trachana, Luciana Romano-Palumbo, Deborah Bielser, Cédric Howald, Cristina Pamfil, Antonis Fanouriakis, Δέσποινα Κοσμαρά, Argyro Repa, Prodromos Sidiropoulos, Emmanouil T. Dermitzakis, Dimitrios T. Boumpas
出版 2019Artigo
相關主題
Internal medicine
Medicine
Disease
Immunology
Systemic lupus erythematosus
Antibody
Cohort
Arthritis
Biology
Cohort study
Immune system
Lupus erythematosus
Lupus nephritis
Pathology
Rheumatoid arthritis
Adverse effect
Alternative medicine
Anakinra
Anti-nuclear antibody
Autoantibody
B cell
B-cell activating factor
Belimumab
Canakinumab
Caspase 1
Comorbidity
Computer science
Confidence interval
Coronavirus disease 2019 (COVID-19)
Cytokine